Founded in 1989, LKT Laboratories develops high-purity small molecules and biochemicals for life science research. The company specialises in the synthesis, purification and isolation of biologically active compounds for experimental studies. Its expertise includes protein kinase inhibitors, ion channel modulators, pathway activators and natural products. These reagents help researchers investigate cellular signalling, disease mechanisms and therapeutic targets. The portfolio supports research in cancer biology, neuroscience, cardiovascular science, microbiology, immunology and metabolic disease. Scientific capabilities also include natural product isolation, analytical characterisation and custom research services.
The product range includes research chemicals, peptides, analytical standards, reference materials and natural products. Key product groups include carotenoids, flavonoids, ginsenosides, isothiocyanates, antioxidants and other biologically active compounds. The catalogue also features Taxol impurity standards and compounds for in vitro and in vivo studies. These products support drug discovery, pathway analysis, cell-based assays, pharmacology research and analytical method development. Researchers use these reagents to study biological activity, validate experimental models and characterise molecular mechanisms.
Europa Biosite subsidiaries distribute LKT Laboratories products in Germany, Ireland, Switzerland and the United Kingdom
